Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) was the target of a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 4,920,000 shares, a decline of 20.3% from the July 31st total of 6,170,000 shares. Currently, 6.5% of the shares of the company are […]